Published guidance, NICE advice and quality standards | Guidance

Showing 151 to 160 of 797

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Tezepelumab for treating severe asthma	TA880	20 April 2023	20 April 2023
Trastuzumab deruxtecan for treating HER2-positive unresectable or metastatic gastric or gastro-oesophageal junction cancer after anti-HER2 treatment (terminated appraisal)	TA879	6 April 2023	6 April 2023
Finerenone for treating chronic kidney disease in type 2 diabetes	TA877	23 March 2023	23 March 2023
Nivolumab with chemotherapy for neoadjuvant treatment of resectable non-small-cell lung cancer	TA876	22 March 2023	22 March 2023
Eptinezumab for preventing migraine	TA871	1 March 2023	1 March 2023
Cannabidiol for treating seizures caused by tuberous sclerosis complex	TA873	1 March 2023	1 March 2023
Polatuzumab vedotin in combination for untreated diffuse large B-cell lymphoma	TA874	1 March 2023	1 March 2023
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies	TA872	28 February 2023	28 February 2023
Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma	TA870	22 February 2023	22 February 2023
Mitapivat for treating pyruvate kinase deficiency (terminated appraisal)	TA867	16 February 2023	16 February 2023